Profile - To The Moon

Aina24

Posts · 4Posts · 4
Following · 0Following · 0
Followers · 0Followers · 0

- Aina24Aina24
  ·2021-05-28
  good
  EU regulator endorses Pfizer-BioNTech COVID-19 vaccine for adolescents
  May 28 (Reuters) - Europe's medicines regulator on Friday backed the use of Pfizer's COVID-19 vac
  EU regulator endorses Pfizer-BioNTech COVID-19 vaccine for adolescents
  462 2
  1
  Share
  Report
- Aina24Aina24
  ·2021-05-27
  $Starbucks(SBUX)$huat
  555 5
  3
  Share
  Report
- Aina24Aina24
  ·2021-05-12
  wow
  Amazon Stock Will Shine Post-Bezos and Post-Pandemic
  Amazon will remain the dominant force as it moves into a new era. As Jeff Bezos’ term as CEO winds
  Amazon Stock Will Shine Post-Bezos and Post-Pandemic
  197 Comment
  Like
  Share
  Report
- Aina24Aina24
  ·2021-05-12
  wow
  Apple, Netflix and 17 More Stocks Investors Are Selling That Wall Street Loves
  Finding the market’s diamonds in the rough—stocks with big potential that other investors haven’t no
  Apple, Netflix and 17 More Stocks Investors Are Selling That Wall Street Loves
  266 Comment
  Like
  Share
  Report

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3583841690595002","uuid":"3583841690595002","gmtCreate":1620749451559,"gmtModify":1620784469533,"name":"Aina24","pinyin":"aina24","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/a82bf3291db7879634f601e8c75746a3","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":24,"tweetSize":4,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.02.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":134144414,"gmtCreate":1622212871838,"gmtModify":1704181674455,"author":{"id":"3583841690595002","authorId":"3583841690595002","name":"Aina24","avatar":"https://static.tigerbbs.com/a82bf3291db7879634f601e8c75746a3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583841690595002","idStr":"3583841690595002"},"themes":[],"htmlText":"good","listText":"good","text":"good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/134144414","repostId":"2138488686","repostType":4,"repost":{"id":"2138488686","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1622212695,"share":"https://ttm.financial/m/news/2138488686?lang=&edition=fundamental","pubTime":"2021-05-28 22:38","market":"us","language":"en","title":"EU regulator endorses Pfizer-BioNTech COVID-19 vaccine for adolescents","url":"https://stock-news.laohu8.com/highlight/detail?id=2138488686","media":"Reuters","summary":"May 28 (Reuters) - Europe's medicines regulator on Friday backed the use of Pfizer's    COVID-19 vac","content":"<p>May 28 (Reuters) - Europe's medicines regulator on Friday backed the use of Pfizer's    COVID-19 vaccine for children as young as 12, paving way for a broader roll-out in the region after similar clearances in the United States and Canada.</p><p>The European Medicines Agency's endorsement comes weeks after it began evaluating extending use of the vaccine, developed with Germany's BioNTech   , to include 12- to 15-year olds. It is already being used in the European Union for those aged 16 and older.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EU regulator endorses Pfizer-BioNTech COVID-19 vaccine for adolescents</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEU regulator endorses Pfizer-BioNTech COVID-19 vaccine for adolescents\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-05-28 22:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>May 28 (Reuters) - Europe's medicines regulator on Friday backed the use of Pfizer's    COVID-19 vaccine for children as young as 12, paving way for a broader roll-out in the region after similar clearances in the United States and Canada.</p><p>The European Medicines Agency's endorsement comes weeks after it began evaluating extending use of the vaccine, developed with Germany's BioNTech   , to include 12- to 15-year olds. It is already being used in the European Union for those aged 16 and older.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2138488686","content_text":"May 28 (Reuters) - Europe's medicines regulator on Friday backed the use of Pfizer's    COVID-19 vaccine for children as young as 12, paving way for a broader roll-out in the region after similar clearances in the United States and Canada.The European Medicines Agency's endorsement comes weeks after it began evaluating extending use of the vaccine, developed with Germany's BioNTech   , to include 12- to 15-year olds. It is already being used in the European Union for those aged 16 and older.","news_type":1},"isVote":1,"tweetType":1,"viewCount":462,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":132502882,"gmtCreate":1622096443846,"gmtModify":1704179393263,"author":{"id":"3583841690595002","authorId":"3583841690595002","name":"Aina24","avatar":"https://static.tigerbbs.com/a82bf3291db7879634f601e8c75746a3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583841690595002","idStr":"3583841690595002"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SBUX\">$Starbucks(SBUX)$</a>huat&nbsp;","listText":"<a href=\"https://laohu8.com/S/SBUX\">$Starbucks(SBUX)$</a>huat&nbsp;","text":"$Starbucks(SBUX)$huat","images":[{"img":"https://static.tigerbbs.com/bf22307a3938cf0e353dc74830e3550c","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":5,"repostSize":1,"link":"https://ttm.financial/post/132502882","isVote":1,"tweetType":1,"viewCount":555,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3583841690595002","authorId":"3583841690595002","name":"Aina24","avatar":"https://static.tigerbbs.com/a82bf3291db7879634f601e8c75746a3","crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3583841690595002","idStr":"3583841690595002"},"content":"[Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger]","text":"[Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger]","html":"[Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger] [Anger]"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":193397165,"gmtCreate":1620752377557,"gmtModify":1704347899364,"author":{"id":"3583841690595002","authorId":"3583841690595002","name":"Aina24","avatar":"https://static.tigerbbs.com/a82bf3291db7879634f601e8c75746a3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583841690595002","idStr":"3583841690595002"},"themes":[],"htmlText":"wow","listText":"wow","text":"wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/193397165","repostId":"1104202222","repostType":4,"repost":{"id":"1104202222","pubTimestamp":1620743110,"share":"https://ttm.financial/m/news/1104202222?lang=&edition=fundamental","pubTime":"2021-05-11 22:25","market":"us","language":"en","title":"Amazon Stock Will Shine Post-Bezos and Post-Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1104202222","media":"InvestorPlace","summary":"Amazon will remain the dominant force as it moves into a new era.\n\nAs Jeff Bezos’ term as CEO winds ","content":"<blockquote>\n <b>Amazon will remain the dominant force as it moves into a new era.</b>\n</blockquote>\n<p>As Jeff Bezos’ term as CEO winds down,<b>Amazon</b>(NASDAQ:<b><u>AMZN</u></b>) stock continues to march upward.</p>\n<p>Back in February Amazon announced that Bezos would be transitioning out of his role as CEO in Q3. He’ll assume the title of Executive Chair at that time, and Andy Jassy will become CEO.</p>\n<p>Fundamentally, it means that an end to an era is approaching. That has the market wondering whether Amazon will see some degree of decline.</p>\n<p>I’ll start by saying that I believe very little will change. That’s a good thing.</p>\n<p>Maybe Amazon will institute a dividend, or perhaps it’ll undertake a stock-split. Whether it does either, neither, or both of those things, Amazon is still a worthwhile investment.</p>\n<p><b>Recent Results and AMZN Stock</b></p>\n<p>Even though Jeff Bezos is easing away from his CEO role, Amazon continues to perform incredibly well. In Q1 ‘21, net sales at Amazon increased by 44% year-over-year, to $108.5 billion.</p>\n<p><b>Walmart</b>(NYSE:<b><u>WMT</u></b>), by comparison, netted $134.6 billion: A larger number in absolute terms, yet its 8.7% revenue increase was much lower than Amazon’s 44% increase.</p>\n<p>If that comparison makes you uneasy from an investment perspective (although it shouldn’t) then consider another often made comparison. That between Chinese ecommerce giant<b>Alibaba</b>(NYSE:<b><u>BABA</u></b>) and Amazon.</p>\n<p>Amazon’s Q1 2021 revenues of $108.5 billion are 50.69% greater than the $72 billion the Amazon of China made in all of fiscal year 2020.</p>\n<p>Further, at Amazon, income in Q1 reached $8.1 billion, more than triple what it was a year prior.</p>\n<p>So ignore bearish sentiment dictates that somehow Amazon’s best days are behind it. It really is overall a company that just keeps winning.</p>\n<p>Amazon has shown its value in our limited contact, pandemic-ridden world. One might expect that it simply can’t continue to exceed expectations.</p>\n<p>However, it keeps proving that it can. Analysts expected Amazon to report $104 billion in revenues in Q1, it beat the estimates with that $108.5 billion figure.</p>\n<p>When you look at AMZN stock and its $3,300 price tag it could easily give you pause. But then its important to consider the company’s track record and Wall Street’s opinion of it.</p>\n<p>Just about every one of the more than 50 analysts with coverage of Amazon consider it a buy. Their average price target indicates 27.3% upside.</p>\n<p>That should lend a fair amount of confidence to anyone on the fence about buying Amazon shares.</p>\n<p><b>Is Amazon’s Growth Pandemic Bound</b></p>\n<p>The short answer is no. Amazon was huge back in 2016, recording $135 billion in revenues. Those revenues more than doubled by 2019 when it recorded $280 billion in sales.</p>\n<p>In 2020 revenues hit $386 billion. Yes, that was a revenue increase that was historically out of line. And yes, it was due to the pandemic. So it’s rational to believe that in the wake of the pandemic that sales will naturally return to a more average growth rate.</p>\n<p>So maybe revenues will increase by $50 billion annually (2018-2019), and not by $100 billion as in 2019 to 2020. But so what?</p>\n<p>I’d be astounded if Amazon doesn’t find a way to take the windfall proceeds from the pandemic and turn them into a future business that grows that massive top line.</p>\n<p>Amazon states that its focus is on long-term sustainable growth in free cash flows. Judged by that metric, Amazon again does well. For the trailing twelve months ended March 31, free cash flows increased to $26.4 billion from $24.3 billion in the corresponding previous period.</p>\n<p><b>Takeaway</b></p>\n<p>Amazon remains a strong buy despite its sticker price. Worry less about the upcoming CEO transition and focus on its sustained growth outside of these extraordinary times.</p>\n<p><i>On the date of publication, Alex Sirois did not have (either directly or indirectly) any positions in the securities mentioned in this article.</i></p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amazon Stock Will Shine Post-Bezos and Post-Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon Stock Will Shine Post-Bezos and Post-Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-11 22:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/amazon-stock-will-shine-post-bezos-and-post-pandemic/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Amazon will remain the dominant force as it moves into a new era.\n\nAs Jeff Bezos’ term as CEO winds down,Amazon(NASDAQ:AMZN) stock continues to march upward.\nBack in February Amazon announced that ...</p>\n\n<a href=\"https://investorplace.com/2021/05/amazon-stock-will-shine-post-bezos-and-post-pandemic/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"source_url":"https://investorplace.com/2021/05/amazon-stock-will-shine-post-bezos-and-post-pandemic/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104202222","content_text":"Amazon will remain the dominant force as it moves into a new era.\n\nAs Jeff Bezos’ term as CEO winds down,Amazon(NASDAQ:AMZN) stock continues to march upward.\nBack in February Amazon announced that Bezos would be transitioning out of his role as CEO in Q3. He’ll assume the title of Executive Chair at that time, and Andy Jassy will become CEO.\nFundamentally, it means that an end to an era is approaching. That has the market wondering whether Amazon will see some degree of decline.\nI’ll start by saying that I believe very little will change. That’s a good thing.\nMaybe Amazon will institute a dividend, or perhaps it’ll undertake a stock-split. Whether it does either, neither, or both of those things, Amazon is still a worthwhile investment.\nRecent Results and AMZN Stock\nEven though Jeff Bezos is easing away from his CEO role, Amazon continues to perform incredibly well. In Q1 ‘21, net sales at Amazon increased by 44% year-over-year, to $108.5 billion.\nWalmart(NYSE:WMT), by comparison, netted $134.6 billion: A larger number in absolute terms, yet its 8.7% revenue increase was much lower than Amazon’s 44% increase.\nIf that comparison makes you uneasy from an investment perspective (although it shouldn’t) then consider another often made comparison. That between Chinese ecommerce giantAlibaba(NYSE:BABA) and Amazon.\nAmazon’s Q1 2021 revenues of $108.5 billion are 50.69% greater than the $72 billion the Amazon of China made in all of fiscal year 2020.\nFurther, at Amazon, income in Q1 reached $8.1 billion, more than triple what it was a year prior.\nSo ignore bearish sentiment dictates that somehow Amazon’s best days are behind it. It really is overall a company that just keeps winning.\nAmazon has shown its value in our limited contact, pandemic-ridden world. One might expect that it simply can’t continue to exceed expectations.\nHowever, it keeps proving that it can. Analysts expected Amazon to report $104 billion in revenues in Q1, it beat the estimates with that $108.5 billion figure.\nWhen you look at AMZN stock and its $3,300 price tag it could easily give you pause. But then its important to consider the company’s track record and Wall Street’s opinion of it.\nJust about every one of the more than 50 analysts with coverage of Amazon consider it a buy. Their average price target indicates 27.3% upside.\nThat should lend a fair amount of confidence to anyone on the fence about buying Amazon shares.\nIs Amazon’s Growth Pandemic Bound\nThe short answer is no. Amazon was huge back in 2016, recording $135 billion in revenues. Those revenues more than doubled by 2019 when it recorded $280 billion in sales.\nIn 2020 revenues hit $386 billion. Yes, that was a revenue increase that was historically out of line. And yes, it was due to the pandemic. So it’s rational to believe that in the wake of the pandemic that sales will naturally return to a more average growth rate.\nSo maybe revenues will increase by $50 billion annually (2018-2019), and not by $100 billion as in 2019 to 2020. But so what?\nI’d be astounded if Amazon doesn’t find a way to take the windfall proceeds from the pandemic and turn them into a future business that grows that massive top line.\nAmazon states that its focus is on long-term sustainable growth in free cash flows. Judged by that metric, Amazon again does well. For the trailing twelve months ended March 31, free cash flows increased to $26.4 billion from $24.3 billion in the corresponding previous period.\nTakeaway\nAmazon remains a strong buy despite its sticker price. Worry less about the upcoming CEO transition and focus on its sustained growth outside of these extraordinary times.\nOn the date of publication, Alex Sirois did not have (either directly or indirectly) any positions in the securities mentioned in this article.","news_type":1},"isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":193394466,"gmtCreate":1620752280755,"gmtModify":1704347898376,"author":{"id":"3583841690595002","authorId":"3583841690595002","name":"Aina24","avatar":"https://static.tigerbbs.com/a82bf3291db7879634f601e8c75746a3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583841690595002","idStr":"3583841690595002"},"themes":[],"htmlText":"wow","listText":"wow","text":"wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/193394466","repostId":"1120132081","repostType":4,"repost":{"id":"1120132081","pubTimestamp":1620739174,"share":"https://ttm.financial/m/news/1120132081?lang=&edition=fundamental","pubTime":"2021-05-11 21:19","market":"us","language":"en","title":"Apple, Netflix and 17 More Stocks Investors Are Selling That Wall Street Loves","url":"https://stock-news.laohu8.com/highlight/detail?id=1120132081","media":"Barron's","summary":"Finding the market’s diamonds in the rough—stocks with big potential that other investors haven’t no","content":"<p>Finding the market’s diamonds in the rough—stocks with big potential that other investors haven’t noticed–isn’t easy, especially with large companies. Dozens of Wall Street firms track their every move, so there is plenty of publicly available analysis that should keep investors up to speed.</p><p>Sometimes, however, it can take a while for investors to focus on what analysts are saying. That can spell opportunity, and it happens surprisingly often.</p><p>Barron’s found 19 S&amp;P 500 stocks, including giants such as Apple (ticker: AAPL) and Netflix (NFLX), with improving analyst sentiment as well as declining stock prices. If the analysts are right, then that paradox could resolve itself with the 19 stocks outperforming the market in coming months.</p><p>The criteria for our latest screen were threefold. For starters, analysts had to be getting more bullish, with more rating upgrades than downgrades over the past three months.</p><p>Next, a greater share of analysts than average had to like each stock. The average Buy-rating ratio for stocks in the S&amp;P is about 55%, so every stock that made the cut scored above that level. No companies with just a few Buy calls and lots of Sell ratings were included, even if they caught a few upgrades in recent weeks.</p><p>Finally, the stocks’ prices had to have fallen over the past three months, as evidence that sentiment among investors hasn’t caught up with analysts’ optimism. That distinguishes our list from the many companies that perform strongly after upgrades on Wall Street.</p><p>Textron (TXT), for example, has picked up four upgrades to Buy in the past three months as analysts focus on how the industrial conglomerate is benefiting from an economic recovery. Its stock is up more than 40% over the same span.</p><p>The 19 stocks with potential pop are, in no particular order: Paycom Software (PAYC), Tyler Technologies (TYL), Verisk Analytics (VRSK), Nextera Energy (NEE), AES (AES), Akamai Technologies (AKAM), Align Technology (ALGN), Thermo Fisher Scientific (TMO), Apple, Adobe (ADBE), IPG Photonics (IPGP), Monolithic Power Systems (MPWR), Leidos (LDOS), Hologic (HOLX) Eli Lilly (LLY), Netflix, Synopsys (SNPS), ServiceNow (NOW) and Advanced Micro Devices (AMD).</p><p>Overall, the 19 stocks are down an average of about 8% over the past three months. The S&amp;P 500, for comparison, is up about 8% over the same span.</p><p><b>Improving Analyst Sentiment</b></p><p>Analysts are warming to these stocks while investors sit on the sidelines.</p><p><img src=\"https://static.tigerbbs.com/c77bd0ba2b4260cb1278d458ba477a61\" tg-width=\"1080\" tg-height=\"1436\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/2143b98c8e5fea063a995608a28eab1f\" tg-width=\"1242\" tg-height=\"288\" referrerpolicy=\"no-referrer\"></p><p>The stocks trade at an average of about 33 times the per-share earnings expected for 2022, which is a premium to the overall market, at about 20.5 times. That is one reason shares might be lagging.</p><p>Value-oriented stocks, which tend to have lower price/earnings ratios, have beaten growth stocks lately. The Russell 1000 Value Index is up about 14% over the past three months, outperforming the Russell 1000 Growth Index by about 13 percentage points.</p><p>For some of the 19 stocks to rise, investors might have to shift back to growth—the darling of the pandemic—from value. That isn’t a sure bet, given that the postpandemic boom is drawing investors to cyclical names, which like value shares, tend to have lower valuations.</p><p>But many of the companies on the list, including the tech names, are impressive, blue-chip firms. It might be a good time to snatch up those stocks before investors, overall, catch on that Wall Street sees brighter days ahead.</p><p>A&nbsp;stock screen, of course, isn’t an investment thesis. It is a way for fundamentally minded investors to narrow down their choices and start kicking the tires on stocks.</p>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple, Netflix and 17 More Stocks Investors Are Selling That Wall Street Loves</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple, Netflix and 17 More Stocks Investors Are Selling That Wall Street Loves\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-11 21:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/apple-netflix-and-17-more-stocks-investors-are-selling-that-wall-street-loves-51620682915?mod=hp_LATEST><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Finding the market’s diamonds in the rough—stocks with big potential that other investors haven’t noticed–isn’t easy, especially with large companies. Dozens of Wall Street firms track their every ...</p>\n\n<a href=\"https://www.barrons.com/articles/apple-netflix-and-17-more-stocks-investors-are-selling-that-wall-street-loves-51620682915?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNPS":"新思科技","AMD":"美国超微公司","IPGP":"IPG光电","AAPL":"苹果","LLY":"礼来","AES":"爱依斯电力","HOLX":"豪洛捷","PAYC":"Paycom Software, Inc.","ADBE":"Adobe","LDOS":"Leidos Holdings Inc","NOW":"ServiceNow","VRSK":"Verisk Analytics","NEE":"新纪元能源","AKAM":"阿克迈","TMO":"赛默飞世尔","TYL":"泰勒科技","NFLX":"奈飞","ALGN":"艾利科技"},"source_url":"https://www.barrons.com/articles/apple-netflix-and-17-more-stocks-investors-are-selling-that-wall-street-loves-51620682915?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1120132081","content_text":"Finding the market’s diamonds in the rough—stocks with big potential that other investors haven’t noticed–isn’t easy, especially with large companies. Dozens of Wall Street firms track their every move, so there is plenty of publicly available analysis that should keep investors up to speed.Sometimes, however, it can take a while for investors to focus on what analysts are saying. That can spell opportunity, and it happens surprisingly often.Barron’s found 19 S&P 500 stocks, including giants such as Apple (ticker: AAPL) and Netflix (NFLX), with improving analyst sentiment as well as declining stock prices. If the analysts are right, then that paradox could resolve itself with the 19 stocks outperforming the market in coming months.The criteria for our latest screen were threefold. For starters, analysts had to be getting more bullish, with more rating upgrades than downgrades over the past three months.Next, a greater share of analysts than average had to like each stock. The average Buy-rating ratio for stocks in the S&P is about 55%, so every stock that made the cut scored above that level. No companies with just a few Buy calls and lots of Sell ratings were included, even if they caught a few upgrades in recent weeks.Finally, the stocks’ prices had to have fallen over the past three months, as evidence that sentiment among investors hasn’t caught up with analysts’ optimism. That distinguishes our list from the many companies that perform strongly after upgrades on Wall Street.Textron (TXT), for example, has picked up four upgrades to Buy in the past three months as analysts focus on how the industrial conglomerate is benefiting from an economic recovery. Its stock is up more than 40% over the same span.The 19 stocks with potential pop are, in no particular order: Paycom Software (PAYC), Tyler Technologies (TYL), Verisk Analytics (VRSK), Nextera Energy (NEE), AES (AES), Akamai Technologies (AKAM), Align Technology (ALGN), Thermo Fisher Scientific (TMO), Apple, Adobe (ADBE), IPG Photonics (IPGP), Monolithic Power Systems (MPWR), Leidos (LDOS), Hologic (HOLX) Eli Lilly (LLY), Netflix, Synopsys (SNPS), ServiceNow (NOW) and Advanced Micro Devices (AMD).Overall, the 19 stocks are down an average of about 8% over the past three months. The S&P 500, for comparison, is up about 8% over the same span.Improving Analyst SentimentAnalysts are warming to these stocks while investors sit on the sidelines.The stocks trade at an average of about 33 times the per-share earnings expected for 2022, which is a premium to the overall market, at about 20.5 times. That is one reason shares might be lagging.Value-oriented stocks, which tend to have lower price/earnings ratios, have beaten growth stocks lately. The Russell 1000 Value Index is up about 14% over the past three months, outperforming the Russell 1000 Growth Index by about 13 percentage points.For some of the 19 stocks to rise, investors might have to shift back to growth—the darling of the pandemic—from value. That isn’t a sure bet, given that the postpandemic boom is drawing investors to cyclical names, which like value shares, tend to have lower valuations.But many of the companies on the list, including the tech names, are impressive, blue-chip firms. It might be a good time to snatch up those stocks before investors, overall, catch on that Wall Street sees brighter days ahead.A stock screen, of course, isn’t an investment thesis. It is a way for fundamentally minded investors to narrow down their choices and start kicking the tires on stocks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":266,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}